At a glance
ClinicalIndex Comparison RecordN/ACompleted· 40 enrolled
Drug / intervention
Insulin Glargine +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effectiveness of Subcutaneous Glargine On The Time To Closure of The Anion Gap in Patients Presenting to the Emergency Department With Diabetic Keto-acidosis: A Pilot Study
The University of Texas Health Science Center, Houston·interventional·Posted Dec 10, 2013·Updated May 16, 2017
In Brief
A clinical study evaluating Insulin Glargine and Regular Insulin for Diabetic Ketoacidosis. Completed, enrolled 40 participants across 2 sites.
Detailed Summary
To determine if co-administration of subcutaneous (SQ)Insulin glargine in combination with intravenous (IV) insulin decreases the time to resolution of ketoacidosis and requirement for ICU admission compared to IV insulin with delayed administration of SQ glargine for the treatment of diabetic ketoacidosis (DKA).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetic Ketoacidosis
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2012
Primary CompletionApr 2013
First PostedDec 2013
TodayJul 2026
First PostedDec 10, 2013
Enrollment StartNov 1, 2012
Primary CompletionApr 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 12.6 years ago
Interventions
Insulin Glarginedrug
Regular Insulindrug